McKesson Corporation (MCK)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 455.66 |
| Open | 457.27 |
| Bid | 456.96 x 800 |
| Ask | 463.86 x 1100 |
| Day's range | 450.98 - 458.10 |
| 52-week range | 331.75 - 476.35 |
| Volume | |
| Avg. volume | 773,442 |
| Market cap | 60.928B |
| Beta (5Y monthly) | 0.54 |
| PE ratio (TTM) | 18.11 |
| EPS (TTM) | 25.28 |
| Earnings date | 30 Jan 2024 - 05 Feb 2024 |
| Forward dividend & yield | 2.48 (0.54%) |
| Ex-dividend date | 30 Nov 2023 |
| 1y target est | 499.33 |
Motley FoolThis 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
Bigtime medical distributors like McKesson (NYSE: MCK) and Cencora (NYSE: COR) make money by moving drugs and supplies to clinics and pharmacies worldwide. If you guessed Ozempic, the medication made by Novo Nordisk for type 2 diabetes, you're correct. Along with the drug's other formulations called Wegovy and Rybelsus, which are indicated for helping people to lose weight, Ozempic belongs to a class of medications called GLP-1 agonists.
ZacksMcKesson (MCK) Announces Availability of FDA-Cleared Drug
The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for breast cancer.
ZacksMcKesson (MCK) Up 5.1% Since Last Earnings Report: Can It Continue?
McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2023 Yahoo. All rights reserved.